Agios Pharmaceuticals (AGIO) EBT Margin Growth (1y) (2013 - 2026)
Agios Pharmaceuticals (AGIO) EBT Margin Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,526.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Agios Pharmaceuticals | 2.13 Bn | 2.13 Bn | 19.43 Mn | 56,518.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56,518.00 |
| Dec 31, 2025 | 43,611.00 |
| Sep 30, 2025 | -1.20 Mn |
| Jun 30, 2025 | 22,304.00 |
| Mar 31, 2025 | -9,624.00 |
| Dec 31, 2024 | 36,841.00 |
| Sep 30, 2024 | 1.24 Mn |
| Jun 30, 2024 | 5,814.00 |
| Mar 31, 2024 | 37,067.00 |
| Dec 31, 2023 | 90,241.00 |
| Sep 30, 2023 | 137,357.00 |
| Jun 30, 2023 | 45,542.00 |
| Mar 31, 2023 | 1.10 Mn |
| Dec 31, 2020 | 10,899.00 |
| Sep 30, 2020 | 18,830.00 |
| Jun 30, 2020 | 21,301.00 |
| Mar 31, 2020 | 22,163.00 |
| Dec 31, 2019 | 130,686.00 |
| Sep 30, 2019 | 22,038.00 |
| Jun 30, 2019 | -25,518.00 |